Up next
Share article
The post has been shared by 0 people.
Mail 0
LinkedIn 0
Twitter 0

Podcast 15: Tracking Expansion in High-Potency Manufacturing

In this podcast, we round up key recent expansions in high-potency manufacturing by CDMOs and CMOs. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

  • Expansions in high-potency manufacturing
  • Lonza
  • WuXi AppTec
  • Seqens
  • Cambrex
  • Piramal Pharma Solutions
  • CordenPharma
  • Flamma
  • Cerbios-Pharma
  • Evonik
  • AGC
  • Novasep
  • Ajinomoto Bio-Pharma Services
  • BSP Pharmaceuticals
  • PCI Pharma Services
  • Sterling Pharma Solutions
  • Heraeus
  • Procos
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Podcast 44: What’s Trending: Parenteral Drug Development & Manufacturing

What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights…

Podcast 43: CDMOs/CMOs: The Movers and Shakers of 2023

As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the…

Podcast 42: CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023 

As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an…

Podcast 41: API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains 

The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages…